retatrutide phase 2 Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released trial results demonstrating 25% weight loss in half of people with #obesity. This amount of weight loss has not been accomplished obesity #retatrutide #weight #glp1 #nejm

Fortunately, for most of us, it's just an occasional occurrence that goes away with time

Gallic acid mitigates diclofenac-induced liver toxicity by modulating oxidative stress and suppressing IL-1 gene expression in male rats

Grobbelaar LM, Venter C, Vlok M, Ngoepe M, Laubscher GJ, Lourens PJ, et al

Yeast supplementation has also been shown to reduce oxidative stress by lowering malondialdehyde (MDA) levels, a marker of lipid peroxidation

Harper believes that clinicians should start subtyping lesions and treat all the lesions that are observed, even if that means use of multiple therapeutic agents

doi: 10.1016/j.pnpbp.2005.03.004